Trademarks

After $31 million award inventor swaps East Texas for Washington and takes his PTAB fight to Congress

Josh Malone’s Bunch O Balloons success has made him a leading figure in the invention community and positioned him to challenge some of the patent narratives on Capitol Hill

After $31 million award inventor swaps East Texas for Washington and takes his PTAB fight to Congress
7 Jun 2019

China overhauls criminal IP enforcement

Food and drug authorities will take responsibility for criminal IP investigations, as government re-shuffle continues. It’s good news for pharma IP owners – others may have questions

3 Jun 2019

Deloitte makes major IP play with acquisition of top advisory

Big Four firm closes deal to acquire UK-based ClearView in a further sign that IP value creation is moving to the centre of the corporate agenda 

Latest

View all
3 Jun 2019

Shenzhen-based operating company tapped to license foreign pool's China rights

Netac’s own killer patent is set to expire later this year. But according to demand letters circulating Chinese media, the memory maker's IP team is now partnering with a patent pool formed by Panasonic, Toshiba and SanDisk Read more

30 May 2019

AB InBev IP exec explains how he is helping to shift attitudes one six-pack at a time

With the giant brewer facing off against Heineken in court, Michael Swita sets out how innovation and patents are becoming a far bigger consideration in the industry Read more

28 May 2019

US biotech aims to curb China’s genomics leader with pair of European lawsuits

Shenzhen BGI was once the biggest purchaser of Illumina’s gene sequencing machines. Now the two are on opposite sides of an expanding patent battle Read more

27 May 2019

Kevin Rivette: what people still get wrong about Rembrandts in the Attic

Twenty years since the publication of his seminal book, the renowned IP thinker explains why some of its messages still don’t hit home Read more

News

View all
22 May 2019

The latest developments from this year's INTA meeting

Our final instalment of news, gossip, views and analysis from the world's biggest IP event, now winding down in Boston   Read more

21 May 2019

All the news from the world's biggest IP event

The annual INTA meeting is now in full swing in Boston, with over 11,000 delegates in attendance. Not surprisingly, there is a lot going on Read more

20 May 2019

The INTA annual meeting kicks off in Boston

An inside look at all the big stories from the opening two days of the world’s biggest IP event Read more

10 May 2019

Bringing video game IP to China: big risks, big payoff

Nintendo has reached a deal with Tencent to bring its lucrative IP to China. It is well-positioned to succeed where other game companies have faltered Read more

Analysis

View all
22 May 2019

Looking to ramp up IP commercialisation in new sectors, Nokia unveils collaboration with GE

Initial stage of relationship will focus on fiber communications technology that can be used in areas such as medtech Read more

7 May 2019

Faraday Future seeks lifeline from $1.25 billion IP valuation

Cash-strapped electric vehicle start-up hopes to attract much-needed funding after Houlihan Lokey estimate of the value of its portfolio, which includes tech, patents and trademarks  Read more

2 May 2019

Backlash against PepsiCo’s Indian plant variety lawsuit highlights IP enforcement difficulties

Company faces major brand backlash after launching a suit against farmers it accused of infringing rights protecting the potato type used to make Lay's crisps Read more

25 Apr 2019

China fast-tracks changes to trade secret law ahead of further talks with Trump administration

Although the move should be seen as a goodwill gesture, the amendments are unlikely to move the needle much in a jurisdiction where enforcement is hampered by the difficulty of collecting evidence Read more

Insights

View all
27 Sep 2018

A Brexit IP issue with serious political consequences

The UPC and EU trademarks will not inflame any Brexit passions among those outside the IP bubble, but geographical indications are a different matter altogether Read more

Find an expert